Healthcare Triangle, Inc. to Announce Q3 2026 Financial Results
Healthcare Triangle, Inc. is scheduled to release its financial results for the third quarter of 2026 on November 5, 2026.
Stocks · News reference
Healthcare Triangle Identifies ~$45M Business Across Hospital, Government, Enterprise Wellness And Neuroscience Programs In Indonesia; No Agreements Signed Yet
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Healthcare Triangle Announces Expansion into Indonesia
Healthcare Triangle, Inc. is expanding its operations into Indonesia through its subsidiary, Quantum Nexis Inc., targeting a potential business opportunity of approximately USD 45 million.
8-K filing — Healthcare Triangle, Inc. (HCTI)
Filed: 2026-10-27 AccNo: 0001213900-26-112972 Size: 255 KB Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Healthcare Triangle Enters Neurotechnology AI Devices and Solutions Market in Southeast Asia
Healthcare Triangle, Inc. has launched a new neurotechnology AI devices and solutions initiative through its subsidiary, Quantum Nexis Inc., targeting markets in Malaysia and Indonesia.
Purpose Health, Inc. Secures Multiple Multi-Year Healthcare IT Agreements
Healthcare Triangle's subsidiary, Purpose Health, Inc., has signed several multi-year agreements, including a Master Services Agreement for EHR optimization and cybersecurity.
Healthcare Triangle, Inc. Announces 1-for-20 Reverse Stock Split
Healthcare Triangle, Inc. has announced a 1-for-20 reverse stock split of its common stock, effective October 26, 2026, to regain compliance with Nasdaq's minimum bid price requirement.